This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other abnormalities of plasma proteins
R18_OTHER_ABNORMALITI_PLASMA_PROTEINS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
572 |
4. Check minimum number of eventsNone |
572 |
5. Include endpointsNone |
572 |
6. Filter based on genotype QC (FinnGen only) |
556 |
Control definitions (FinnGen only)
- Control exclude
- R18_ABNORMAL_FINDI_EXAMI_BLOOD_WO_DIAGNOSIS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R7
- Name in latin
- Aliae abnormitates proteinorum plasmatis
Similar endpoints
↥List of similar endpoints to
Other abnormalities of plasma proteins
based on the number of shared cases.
Similar with more cases:
- Abnormal findings on examination of blood, without diagnosis
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 556 | 277 | 279 |
| Unadjusted period prevalence (%) | 0.11 | 0.10 | 0.13 |
| Median age at first event (years) | 67.12 | 65.29 | 68.93 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 572
- Matched controls
- 5720
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R77.1
ICD-10 Finland
Abnormality of globulin
2556.6
189.6
173
*
R77.0
ICD-10 Finland
Abnormality of albumin
+∞
185.9
168
*
R77.8
ICD-10 Finland
Other specified abnormalities of plasma proteins
804.1
183.5
171
*
R77.9
ICD-10 Finland
Abnormality of plasma protein, unspecified
+∞
69.2
65
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.5
48.7
143
391
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
42.1
145
443
R50.9
ICD-10 Finland
Fever, unspecified
3.8
39.9
155
513
C03CA01
ATC
furosemide; systemic
2.9
34.1
277
1400
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
33.0
30.8
40
13
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
30.7
351
2081
JN4AD
NOMESCO Finland
Body CT examination
3.8
30.3
107
328
D64.9
ICD-10 Finland
Anaemia, unspecified
3.7
29.7
111
353
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
29.1
221
1059
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
27.9
153
614
XW000
NOMESCO Finland
Bone marrow biopsy
5.1
27.1
60
128
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
24.8
224
1152
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
22.9
157
702
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
29.3
21.1
28
10
ZX120
NOMESCO Finland
Intravenous
3.2
20.0
88
307
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
19.2
97
366
H02AB06
ATC
prednisolone; systemic
2.2
19.2
314
2027
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.5
18.6
31
50
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
18.6
97
372
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.6
17.8
63
191
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
17.2
78
276
Z51.5
ICD-10 Finland
Palliative care
3.1
17.2
79
282
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.4
17.0
44
106
N02AA05
ATC
oxycodone; systemic
2.3
16.4
150
754
A02BC02
ATC
pantoprazole; systemic
2.3
16.3
421
3162
A41.9
ICD-10 Finland
Sepsis, unspecified
4.4
16.3
42
101
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
12.2
16.2
29
25
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.8
16.2
30
54
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
15.9
59
184
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
7.1
15.8
24
35
I50.9
ICD-10 Finland
Heart failure, unspecified
2.4
15.5
125
593
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
15.4
156
816
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
15.3
88
354
JN4BD
NOMESCO Finland
Extensive body CT
2.7
14.8
90
373
AA1AD
NOMESCO Finland
CT of head and brain
2.1
14.4
193
1122
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
14.4
105
474
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.1
14.4
40
102
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.8
14.1
44
122
ZXD05
NOMESCO Finland
Urgent procedure
2.0
13.8
199
1186
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
13.7
226
1413
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
13.2
108
513
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.9
13.1
40
109
J94.8
ICD-10 Finland
Other specified pleural conditions
6.3
13.0
22
36
R60.9
ICD-10 Finland
Oedema, unspecified
3.4
12.9
48
150
A46
ICD-10 Finland
Erysipelas
2.3
12.8
108
519
ZXE00
NOMESCO Finland
One hour or less
1.9
12.8
242
1577
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
12.6
173
1007
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.4
12.6
47
147
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.3
12.4
32
77
UJF32
NOMESCO Finland
Coloscopy
2.0
12.3
178
1054
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.7
12.3
40
114
WW200
NOMESCO Finland
Immunization
5.3
12.3
25
49
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
12.3
172
1007
J01MA12
ATC
levofloxacin; systemic
2.1
12.2
133
709
R60.0
ICD-10 Finland
Localized oedema
2.4
12.2
93
427
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.9
12.0
61
229
R11
ICD-10 Finland
Nausea and vomiting
2.6
11.7
70
286
R18
ICD-10 Finland
Ascites
5.4
11.6
23
44
WZC30
NOMESCO Finland
Teaching
2.2
11.5
110
556
SPAT1262
SPAT
Handing over of treatment supplies
2.1
11.5
123
650
N18.8
ICD-10 Finland
Other chronic renal failure
4.5
11.1
27
62
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.5
11.0
38
113
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.0
11.0
31
80
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
10.8
100
498
A11CC03
ATC
alfacalcidol; systemic
4.7
10.8
25
55
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
10.6
212
1385
TK800
NOMESCO Finland
Hemodialysis
5.0
10.6
23
48
A41.8
ICD-10 Finland
Other specified sepsis
4.8
10.6
24
52
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
10.5
238
1617
C03DA01
ATC
spironolactone; oral
2.2
10.4
94
463
B01AB05
ATC
enoxaparin; parenteral
1.8
10.4
204
1324
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.1
10.3
43
144
R06.0
ICD-10 Finland
Dyspnoea
1.9
10.3
180
1127
SPAT1229
SPAT
Assessment of need for aid
2.6
10.2
62
256
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.5
10.2
35
104
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
10.1
227
1532
GD1AD
NOMESCO Finland
Thorax CT examination
2.9
9.7
47
172
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
56.0
9.7
11
*
WX002
NOMESCO Finland
Sedation and analgesia
2.0
9.7
127
721
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
9.6
66
288
WZC00
NOMESCO Finland
Treatment plan or consultation
1.8
9.6
204
1349
UJF92
NOMESCO Finland
Capsular endoscopy
4.9
9.6
21
44
B01AB10
ATC
tinzaparin; parenteral
2.4
9.5
71
323
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
9.4
69
311
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.0
9.4
20
41
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.5
9.4
61
260
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.8
9.3
47
176
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.3
9.2
72
333
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
9.2
58
243
B01AA03
ATC
warfarin; systemic
1.9
9.2
136
802
L28
ICPC
Limited function/disability (L)
2.0
9.2
121
687
E87.5
ICD-10 Finland
Hyperkalaemia
4.7
9.1
21
46
L04AX01
ATC
azathioprine; systemic
3.6
9.0
30
87
E83.1
ICD-10 Finland
Disorders of iron metabolism
19.0
9.0
13
7
H02AB09
ATC
hydrocortisone; systemic
4.6
8.9
21
47
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.8
8.9
45
169
J01MA02
ATC
ciprofloxacin; systemic
1.7
8.8
236
1659
B03XA02
ATC
darbepoetin alfa; parenteral
4.2
8.8
23
56
WW500
NOMESCO Finland
Blood transfusion
3.3
8.8
34
109
M35.3
ICD-10 Finland
Polymyalgia rheumatica
3.1
8.8
37
125
A04AA01
ATC
ondansetron; systemic, rectal
2.5
8.8
58
249
J01DB01
ATC
cefalexin; oral
1.9
8.8
467
3977
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
4.9
8.6
19
40
E86
ICD-10 Finland
Volume depletion
4.0
8.5
24
62
I50.0
ICD-10 Finland
Congestive heart failure
2.4
8.5
61
272
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
8.4
140
855
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.7
8.4
17
20
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.7
8.3
44
169
A28
ICPC
Limited function/disability NOS
1.9
8.2
119
695
WX882
NOMESCO Finland
High dependency care
3.7
8.2
26
73
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
4.5
8.2
20
46
R4190
NOMESCO Finland
Nutritional therapy
3.5
8.2
28
83
R53
ICD-10 Finland
Malaise and fatigue
1.8
8.1
152
961
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.4
8.1
20
32
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
8.1
134
817
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
8.1
68
325
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.8
8.0
40
149
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
7.9
80
412
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.3
7.8
20
48
196
Kela drug reimbursment
Paricalcitol and cinacalcet
15.3
7.7
12
8
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
7.7
105
600
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.6
7.7
46
188
Z3231
NOMESCO Finland
Registered nurse
1.7
7.7
163
1067
R4110
NOMESCO Finland
Physiotherapy
1.7
7.5
161
1058
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
7.8
7.4
16
21
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.1
7.4
30
99
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.3
7.4
58
269
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.6
7.3
24
69
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.5
7.3
46
193
L04AA06
ATC
mycophenolic acid; systemic
5.9
7.3
19
33
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
5.9
7.3
19
33
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
6.7
7.2
17
26
F10.09
ICD-10 Finland
Alcohol intoxication UNS
4.1
7.1
19
47
JN4CD
NOMESCO Finland
Very extensive body CT
2.9
7.1
33
118
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.9
7.1
33
118
SPAT1263
SPAT
Sampling
1.6
7.1
234
1713
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.7
7.1
147
954
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
2.9
7.0
33
119
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
7.0
375
3082
SPAT1301
SPAT
No procedures
1.7
6.9
182
1256
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
4.1
6.9
19
48
M04AA01
ATC
allopurinol; systemic
1.9
6.9
91
513
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
14.0
6.9
11
8
N03AX16
ATC
[U] pregabalin
1.7
6.8
139
896
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.0
6.8
80
434
J01MA14
ATC
moxifloxacin; systemic
2.1
6.7
61
301
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
6.7
83
459
C61
ICD-10 Finland
Malignant neoplasm of prostate
2.2
6.7
58
281
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
6.6
61
302
H02AB02
ATC
dexamethasone; systemic
2.0
6.6
73
387
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.1
6.6
27
90
A10AE04
ATC
insulin glargine; parenteral
2.1
6.6
65
331
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
6.6
86
484
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.0
6.6
29
101
N02BE01
ATC
paracetamol; systemic, rectal
2.0
6.5
502
4494
V03AE01
ATC
polystyrene sulfonate; oral
6.3
6.5
16
26
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.6
6.5
38
154
TQW80
NOMESCO Finland
Local dermatologic skincare
3.6
6.5
21
60
A10AB05
ATC
insulin aspart; parenteral
2.3
6.4
51
238
NHQ40
NOMESCO Finland
Amputation of toe
4.1
6.4
17
42
KH1AD
NOMESCO Finland
CT of urinary organs
3.3
6.4
24
76
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.7
6.3
34
132
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
2.2
6.3
54
260
SPAT1254
SPAT
Administration of medicine
1.9
6.3
91
529
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
18.3
6.3
9
5
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.6
6.2
35
139
C07AB07
ATC
bisoprolol; oral
1.6
6.2
292
2300
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.0
6.1
67
355
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
8.7
6.1
12
14
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.2
6.0
48
224
Z49.1
ICD-10 Finland
Extracorporeal dialysis
5.6
6.0
16
29
WX892
NOMESCO Finland
Monitored bed care
2.2
6.0
49
231
M10.9
ICD-10 Finland
Gout, unspecified
2.3
6.0
47
218
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
185
386
6.61
90.38
3.9
2.7
63.05
66.24
g/l
3.49
173
339
143
257
7.09
80.40
3.2
1.7
1.48
1.27
g/l
0.31
134
233
245
722
5.19
80.10
3.7
2.5
11.56
12.76
umol/l
1.50
232
663
105
137
9.16
78.23
4.7
4.5
81.32
51.71
mg/l
0.30
71
112
105
137
9.16
78.23
4.7
4.5
49.75
59.79
mg/l
0.38
72
110
158
325
6.34
77.40
4.5
2.4
10.37
10.18
g/l
0.12
148
291
231
667
5.13
77.00
3.7
2.5
2.11
2.32
g/l
5.29
223
611
224
635
5.15
76.27
3.8
2.5
21.31
22.37
%
0.46
202
542
184
526
4.68
60.34
6.4
4.2
233.34
241.57
u/l
0.47
176
497
400
2073
4.09
54.71
9.7
4.5
31.03
35.26
g/l
24.60
382
1911
178
567
4.11
49.48
2.4
2.4
1.81
1.76
%
0.28
160
510
184
617
3.92
47.31
11.9
5.3
1.07
1.03
mmol/l
1.00
176
563
100
208
5.61
47.12
2.4
1.9
0.79
2.97
ug/l
0.88
95
182
211
778
3.71
47.10
6.3
3.3
0.78
0.81
mmol/l
2.47
206
731
393
2142
3.67
46.84
11.6
5.5
2.79
2.84
%
0.12
379
2001
151
448
4.22
45.98
2.7
2.1
0.19
0.21
g/l
3.09
136
419
82
147
6.34
45.10
5.4
3.2
2.58
1.26
g/l
1.15
72
127
394
2191
3.57
44.59
11.9
5.7
23.33
27.36
%
10.99
379
2053
440
2636
3.90
43.96
16.8
9.1
4.66
4.19
e9/l
3.61
412
2325
389
2165
3.49
43.56
11.1
5.5
61.34
57.50
%
7.37
375
2035
421
2482
3.64
42.44
10.3
6.1
10.30
11.95
umol/l
3.24
408
2350
86
172
5.71
42.12
4.4
2.8
4.01
3.51
g/l
1.14
81
151
86
172
5.71
42.12
4.4
2.8
—
—
—
0
0
86
172
5.71
42.12
4.4
2.8
7.45
7.33
g/l
0.19
81
151
139
416
4.09
41.48
2.6
2.5
70.30
69.63
e9/l
0.08
104
339
265
1203
3.24
41.32
2.7
2.0
3.23
3.19
mg/l
0.10
232
1020
229
987
3.20
38.48
3.7
2.5
4.76
4.79
e6/l
0.02
218
882
74
140
5.92
38.34
2.5
1.5
—
—
—
0
0
79
160
5.57
38.05
4.6
2.9
3.13
2.99
g/l
0.46
74
139
347
1944
3.00
35.66
4.6
2.7
242.44
134.17
ug/l
3.33
325
1769
198
815
3.19
35.55
2.3
1.8
—
—
—
0
0
285
1448
2.93
34.92
4.8
3.2
39.67
111.50
e6/l
0.90
255
1110
392
2365
3.09
34.85
14.6
6.6
1.21
1.21
mmol/l
0.40
320
2023
311
1657
2.92
34.84
5.6
3.7
107.15
133.75
e6/l
0.21
262
1185
199
837
3.11
34.23
2.5
1.4
2.50
2.49
g/l
0.01
156
480
369
2175
2.96
33.84
13.2
5.8
1.20
1.21
mmol/l
2.00
349
1968
387
2355
2.99
33.17
21.4
14.6
1.23
1.28
inr
0.63
149
679
287
1494
2.85
33.13
3.3
2.4
51.51
112.89
u/l
0.59
272
1375
74
161
5.13
32.75
4.8
2.9
10.78
10.49
g/l
0.14
69
139
503
3602
4.29
31.97
15.6
7.4
85.88
78.45
u/l
3.24
491
3341
125
414
3.58
31.56
16.8
6.9
11.31
9.95
mmol/l
1.12
117
389
258
1312
2.76
30.54
4.7
3.1
0.30
0.54
e6/l
1.71
226
986
65
140
5.11
29.02
4.9
3.0
34.26
38.14
g/l
3.38
60
119
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
69
159
4.80
28.44
4.1
2.3
0.41
0.35
u/ml
0.58
43
82
291
1617
2.63
28.23
4.3
3.4
2.31
2.35
mmol/l
5.68
268
1409
145
565
3.10
27.81
2.1
1.8
—
—
—
0
0
79
216
4.08
26.09
2.0
1.9
1.80
1.50
g/l
1.56
65
187
121
439
3.23
26.07
2.5
1.8
355.21
383.69
nmol/l
0.85
114
408
47
84
6.01
25.64
5.6
6.0
183.25
448.29
iu/ml
—
8
14
141
568
2.97
25.28
2.2
1.8
—
—
—
0
0
271
1524
2.48
24.71
4.4
3.1
3279.27
1351.99
ng/l
3.22
254
1308
39
62
6.68
23.84
2.0
1.2
1707.31
1731.02
e6/l
0.01
29
41
229
1210
2.49
23.70
4.2
2.8
6732.63
6990.87
umol/l
0.03
209
1041
55
123
4.84
23.41
1.8
1.5
0.07
0.13
iu/ml
0.30
14
28
40
68
6.25
22.91
1.7
1.4
123.33
107.92
u/ml
—
6
13
165
756
2.66
22.91
4.6
1.9
31.05
29.67
s
1.62
159
729
307
1893
2.34
21.92
3.0
2.2
74.35
77.45
nmol/l
1.07
292
1660
63
166
4.14
21.78
2.5
2.7
—
—
—
0
0
405
2827
2.48
21.57
9.7
4.6
6.88
6.72
mmol/l
0.78
395
2652
35
56
6.59
21.24
2.3
1.8
—
—
—
0
0
462
3442
2.78
21.23
7.7
4.0
21.04
12.43
mm/h
13.20
445
3145
125
516
2.82
21.10
6.4
3.3
—
—
—
0
0
428
3081
2.55
21.01
6.5
4.6
247.29
3542.23
e6/l
—
7
56
52
123
4.55
20.64
2.0
1.4
—
—
—
0
0
195
1010
2.41
20.54
3.6
1.7
1.45
1.16
mg/l
0.94
160
785
218
1186
2.35
20.53
1.7
1.5
20.13
21.15
nmol/l
0.39
201
986
97
354
3.10
20.41
2.4
1.6
—
—
—
0
0
28
37
7.91
20.11
2.5
1.8
—
—
—
0
0
34
61
5.86
18.41
1.6
1.5
31.65
33.02
pg
0.85
34
61
81
285
3.15
18.05
1.8
1.4
—
—
—
0
0
122
537
2.62
17.94
3.6
2.4
6.58
8.93
umol/l
1.14
100
468
32
56
5.99
17.77
1.9
1.2
22005.14
51180.70
e6/l
0.56
22
30
49
125
4.19
17.63
1.8
1.6
—
—
—
0
0
241
1451
2.14
17.00
3.0
2.1
175.87
184.25
u/l
0.12
226
1359
34
66
5.41
16.94
3.6
3.6
606.00
3410.88
u/ml
—
5
8
49
129
4.06
16.90
2.1
1.6
—
—
—
0
0
296
1931
2.10
16.85
6.1
3.8
134.77
57.81
ng/l
0.56
244
1428
37
78
5.00
16.82
6.1
3.3
60.46
58.17
%
0.47
37
78
175
935
2.26
16.60
2.1
1.7
1272.47
1181.55
nmol/l
0.55
143
699
36
75
5.06
16.59
5.5
2.9
4.46
4.66
e9/l
0.15
36
75
43
104
4.39
16.57
3.8
2.4
14.41
16.21
%
1.09
16
50
62
195
3.44
16.53
2.1
2.2
41.65
38.68
u/l
0.41
55
174
106
453
2.64
16.45
9.4
3.4
2.12
2.06
mmol/l
0.05
98
367
40
92
4.60
16.40
2.2
1.8
—
—
—
0
0
106
455
2.63
16.30
9.4
3.4
5.85
5.76
kpa
0.42
106
439
47
125
4.01
15.98
2.1
1.6
—
—
—
0
0
298
1985
2.05
15.63
2.5
2.0
90.54
95.19
pmol/l
0.97
192
1013
49
137
3.82
15.54
1.6
2.1
—
—
—
0
0
237
1457
2.07
15.46
4.1
3.1
39.62
31.30
u/l
1.13
226
1387
85
335
2.81
15.40
5.7
4.1
2.40
1.87
mmol/l
0.63
66
250
94
392
2.67
15.26
10.1
4.0
1.21
1.22
mmol/l
1.46
88
338
394
2928
2.11
15.04
4.7
3.0
72.08
51.01
u/l
2.38
375
2702
23
34
7.01
14.96
1.1
1.1
—
—
u/ml
—
0
0
88
361
2.70
14.74
5.8
4.0
5.36
5.16
kpa
1.18
82
346
35
79
4.65
14.68
1.7
1.3
—
—
—
0
0
33
74
4.67
13.95
1.7
1.3
216.22
265.92
u/ml
0.37
23
36
324
2282
1.97
13.90
5.5
3.8
0.00
0.00
estimate
-0.00
91
410
24
20
12.47
13.70
2.8
2.5
1411.54
816.85
u/ml
0.95
24
20
234
1481
1.98
13.67
4.0
3.0
6.88
7.53
mmol/l
1.47
204
1213
319
2256
1.94
13.29
5.4
3.8
0.00
0.00
estimate
0.50
97
454
31
69
4.69
13.22
2.4
1.7
—
—
—
0
0
140
755
2.13
12.54
4.0
2.9
2.70
2.26
e6/l
0.33
90
430
30
68
4.60
12.52
2.3
1.6
—
—
—
0
0
23
41
5.80
12.51
1.7
2.4
—
—
—
0
0
315
2247
1.89
12.48
6.8
5.2
0.00
0.00
estimate
0.50
94
422
37
100
3.89
12.30
1.3
1.2
—
—
—
0
0
87
387
2.47
12.26
8.2
3.0
4.83
4.57
kpa
0.31
87
372
28
62
4.70
12.01
1.3
1.3
—
—
—
0
0
82
360
2.49
11.87
6.0
3.9
151.69
84.72
ng/l
2.30
74
321
47
154
3.24
11.71
1.3
1.2
—
—
—
0
0
219
1412
1.89
11.68
4.2
3.2
720.15
160.54
mg/l
0.74
155
910
161
949
1.97
11.15
3.2
3.0
2.48
2.45
mmol/l
2.36
146
821
37
108
3.59
11.03
1.6
1.2
—
—
—
0
0
105
531
2.20
10.95
3.3
4.3
307.83
35.60
ug/l
0.46
90
450
22
25
9.11
10.85
2.3
1.8
—
—
—
0
0
303
2199
1.80
10.75
4.0
2.6
—
—
—
0
0
16
10
16.41
10.40
2.1
1.4
—
—
—
0
0
32
88
3.79
10.39
2.3
1.6
—
—
—
0
0
36
108
3.49
10.30
2.3
2.5
32.24
33.08
umol/l
0.08
29
100
169
1042
1.88
10.09
1.7
1.7
97973427.62
11332213.37
pmol/l
0.42
148
856
523
4592
2.62
10.00
42.8
14.9
33.56
25.03
mg/l
5.99
483
3652
13
5
26.54
9.85
1.3
1.4
—
—
—
0
0
194
1258
1.82
9.81
6.1
4.0
0.00
0.01
estimate
0.69
87
409
19
36
5.42
9.69
2.1
1.3
—
—
—
0
0
28
74
3.93
9.61
2.5
1.6
—
—
—
0
0
221
1501
1.77
9.50
5.0
3.7
25.78
8.28
mg/mmol
2.62
157
936
419
3422
1.84
9.34
4.7
3.8
14.92
14.86
pmol/l
0.16
391
3073
25
62
4.17
9.33
1.4
1.4
12.74
17.90
ug/l
1.87
25
62
18
19
9.74
9.32
1.4
1.3
3.43
1.59
%
0.41
18
13
19
38
5.14
9.15
1.2
1.1
—
—
—
0
0
19
38
5.14
9.15
1.2
1.1
—
—
—
0
0
87
440
2.15
9.00
3.4
2.2
29.31
31.11
u/l
0.32
74
371
83
413
2.18
8.94
4.7
3.2
254.73
217.63
ng/l
0.33
75
375
19
39
5.00
8.89
1.2
1.1
—
—
—
0
0
19
39
5.00
8.89
1.2
1.1
—
—
—
0
0
19
39
5.00
8.89
1.2
1.1
—
—
—
0
0
18
21
8.81
8.85
3.1
2.0
—
—
—
0
0
78
380
2.22
8.85
4.6
2.8
49.30
63.81
ml/min/173m2
2.36
33
171
25
65
3.98
8.78
2.6
1.6
—
—
—
0
0
18
22
8.41
8.63
3.1
1.9
—
—
—
0
0
133
797
1.87
8.51
3.7
2.7
1.59
1.03
e6/l
0.95
82
470
175
1143
1.77
8.42
3.7
2.4
—
—
—
0
0
32
102
3.26
8.36
1.4
1.3
—
—
—
0
0
32
102
3.26
8.36
1.4
1.3
—
—
—
0
0
481
4163
1.98
8.22
5.5
4.6
2.03
1.94
mu/l
0.81
454
3753
103
576
1.96
8.08
8.4
6.9
2.00
1.23
mmol/l
0.97
87
456
147
928
1.79
7.88
1.3
1.2
0.99
1.23
u/ml
0.29
34
241
18
26
7.11
7.82
1.7
1.2
—
—
—
0
0
65
309
2.25
7.81
2.2
1.6
—
—
—
0
0
125
754
1.84
7.77
1.4
1.3
51.78
35.25
iu/ml
0.45
52
235
14
14
10.22
7.57
2.0
1.4
—
—
—
0
0
36
131
2.87
7.53
5.8
2.1
89.56
89.50
%
0.00
36
125
19
45
4.33
7.53
1.3
1.1
—
—
—
0
0
18
28
6.60
7.46
3.1
1.8
—
—
—
0
0
31
105
3.06
7.34
1.6
1.4
—
—
—
0
0
329
2604
1.62
7.27
2.9
2.8
—
—
—
0
0
37
141
2.74
7.11
1.4
1.4
233.35
273.92
ug/g
0.51
20
86
528
4792
2.32
6.99
43.1
17.5
3.99
3.99
mmol/l
0.12
520
4651
19
48
4.06
6.94
1.5
1.6
—
—
—
0
0
11
8
13.99
6.91
1.7
3.1
—
—
—
0
0
239
1770
1.60
6.83
5.8
4.0
—
—
—
0
0
526
4779
2.25
6.73
42.4
17.4
138.94
139.65
mmol/l
6.70
518
4644
18
33
5.60
6.66
1.3
1.1
—
—
—
0
0
50
231
2.28
6.44
3.9
3.9
48.35
47.37
%
0.10
50
226
79
438
1.93
6.31
2.5
2.5
6.67
7.25
ug/l
0.11
67
387
9
5
18.25
6.28
1.2
1.0
70.56
86.80
%
—
9
5
115
721
1.74
6.18
1.3
1.3
22.08
10.52
u/ml
0.53
42
265
531
4871
2.26
6.15
21.3
10.4
25.75
25.27
u/l
0.21
522
4689
140
929
1.67
6.11
5.4
3.8
126.29
275.92
ng/l
1.42
119
756
84
488
1.85
5.81
1.6
1.7
1.76
1.51
%
1.00
69
421
17
46
3.78
5.68
1.4
1.3
—
—
—
0
0
12
16
7.63
5.65
1.5
1.3
2.53
4.24
mmol/l
1.07
12
11
10
10
10.15
5.55
1.2
1.0
—
—
—
0
0
12
17
7.19
5.46
5.3
5.7
—
—
—
0
0
10
11
9.23
5.30
1.1
1.0
—
—
—
0
0
21
69
3.12
5.27
1.1
1.1
—
—
—
0
0
13
23
5.76
5.09
1.5
1.7
—
—
—
0
0
13
23
5.76
5.09
1.5
1.7
—
—
—
0
0
51
263
2.03
5.01
3.3
2.8
0.12
0.29
e6/l
1.56
51
255
30
127
2.44
4.73
1.6
1.6
—
—
—
0
0
39
186
2.18
4.69
2.0
1.7
—
—
—
0
0
42
207
2.11
4.66
2.3
1.8
—
—
—
0
0
479
4338
1.64
4.58
33.9
13.8
75.48
78.31
ml/min/173m2
1.58
432
3584
26
107
2.50
4.36
1.5
1.2
639.12
465.42
mg/l
0.42
26
98
25
103
2.49
4.19
2.7
3.2
0.94
0.83
nmol/l
0.48
20
76
14
42
3.39
4.06
2.4
2.2
—
—
—
0
0
19
69
2.81
4.05
1.1
1.1
—
—
—
0
0
9
15
6.08
3.83
3.6
2.9
191.22
224.27
u/l
—
9
15
14
38
3.75
3.82
1.2
1.2
—
79.00
—
0
6
44
239
1.91
3.77
4.6
3.3
24.69
25.15
mmol/l
0.45
44
231
536
5065
1.93
3.65
54.2
21.9
259.35
243.89
e9/l
4.42
527
4931
536
5065
1.93
3.65
55.0
22.0
37.70
39.98
%
12.70
518
4725
536
5068
1.92
3.60
54.1
21.9
4.20
4.46
e12/l
22.25
528
4914
22
93
2.42
3.52
1.5
1.5
—
—
—
0
0
22
93
2.42
3.52
1.5
1.5
—
—
—
0
0
6
6
10.09
3.50
1.0
1.2
—
—
—
0
0
6
6
10.09
3.50
1.7
1.5
—
—
—
0
0
47
268
1.82
3.48
1.2
1.2
41.58
129.06
iu/ml
3.47
15
112
19
76
2.55
3.41
1.1
1.1
51.21
39.88
u/l
0.20
19
64
482
4461
1.51
3.23
5.2
4.7
6.10
6.01
mmol/l
0.75
440
4020
27
131
2.11
3.17
1.7
1.3
—
—
—
0
0
23
105
2.24
3.13
3.7
2.3
122.94
131.12
g/l
0.61
18
79
10
25
4.05
3.09
1.1
1.1
—
—
—
0
0
15
56
2.72
3.08
1.7
1.2
1.67
7.25
u/ml
—
6
16
21
93
2.31
3.07
1.2
1.3
—
—
—
0
0
6
8
7.56
3.06
1.5
1.0
—
—
—
0
0
481
4462
1.49
3.06
4.6
4.5
4.38
4.57
mmol/l
3.26
438
4083
10
26
3.90
2.99
1.4
1.7
—
—
—
0
0
477
4430
1.46
2.89
4.6
4.5
1.42
1.46
mmol/l
1.20
431
4028
11
33
3.38
2.82
1.4
1.6
—
—
—
0
0
11
33
3.38
2.82
1.4
1.6
—
—
—
0
0
463
4283
1.43
2.81
4.3
4.1
1.35
1.27
mmol/l
1.50
416
3868
23
112
2.10
2.71
1.6
1.4
—
—
—
0
0
9
24
3.79
2.68
1.3
1.1
—
—
—
0
0
11
35
3.18
2.65
1.3
1.2
—
—
—
0
0
18
80
2.29
2.63
19.1
1.7
67.34
61.27
%
0.56
18
80
488
4575
1.45
2.59
5.1
5.1
2.49
2.68
mmol/l
4.68
446
4154
11
36
3.10
2.57
1.2
1.0
—
—
—
0
0
9
26
3.50
2.49
1.4
1.7
—
—
—
0
0
9
26
3.50
2.49
1.4
1.7
—
—
—
0
0
7
16
4.42
2.48
2.4
1.6
—
—
—
0
0
8
21
3.85
2.47
1.3
1.4
—
—
—
0
0
26
138
1.93
2.45
2.3
2.4
40.45
108.81
ug/min
1.16
17
84
15
64
2.38
2.40
1.7
1.2
3.50
5.42
u/ml
—
6
26
7
18
3.92
2.26
1.0
1.1
—
—
—
0
0
8
24
3.37
2.18
1.0
1.3
—
—
—
0
0
20
101
2.02
2.18
1.2
1.1
—
—
—
0
0
7
19
3.72
2.15
1.1
1.1
—
—
—
0
0
207
1761
1.27
2.04
6.1
4.7
3.47
2.45
ug/l
1.07
182
1547
6
15
4.03
2.04
1.0
1.0
1912.00
1487.33
miu/ml
—
6
15
10
38
2.66
2.01
1.5
1.5
—
—
—
0
0
13
57
2.31
1.99
5.9
3.7
—
—
—
0
0
12
51
2.38
1.96
1.3
1.6
—
—
—
0
0
12
51
2.38
1.96
1.3
1.6
—
—
—
0
0
12
51
2.38
1.96
1.3
1.6
—
—
—
0
0
13
58
2.27
1.92
1.3
1.1
—
—
—
0
0
8
28
2.88
1.87
1.0
1.0
—
—
—
0
0
123
989
1.31
1.86
3.6
3.0
0.81
0.72
ug/l
0.60
87
657
13
60
2.19
1.79
5.1
4.6
326.62
369.84
umol/l
0.40
13
50
126
1024
1.30
1.76
5.3
4.1
1.02
1.02
kg/l
0.30
18
144
6
18
3.36
1.75
2.2
3.8
65.00
91.06
nmol/l
—
6
18
13
62
2.12
1.66
1.5
1.6
—
—
—
0
0
16
83
1.95
1.66
2.2
2.4
1023.30
5073.27
u/l
—
9
29
10
41
2.46
1.65
1.1
1.0
—
—
—
0
0
5
14
3.59
1.62
1.6
1.1
-1.32
2.73
mmol/l
—
5
14
23
136
1.72
1.61
1.4
1.3
—
—
—
0
0
451
4264
1.27
1.57
7.2
6.0
40.57
40.20
mmol/mol
0.35
422
3921
11
51
2.18
1.51
6.4
2.6
—
—
—
0
0
12
58
2.09
1.50
1.6
1.7
—
—
—
0
0
7
28
2.52
1.45
6.6
1.9
—
—
—
0
0
12
61
1.99
1.33
1.5
1.5
—
—
—
0
0
12
61
1.99
1.33
1.5
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
24
2.52
1.30
1.0
1.2
—
—
—
0
0
142
1214
1.23
1.28
1.9
1.6
1.42
1.34
mmol/l
0.59
108
1002
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
12
62
1.96
1.28
1.8
1.4
—
—
—
0
0
10
48
2.10
1.28
1.0
1.1
—
—
—
0
0
6
25
2.41
1.24
4.2
3.4
—
—
—
0
0
12
63
1.92
1.23
1.8
1.4
—
—
—
0
0
12
63
1.92
1.23
1.8
1.4
—
—
—
0
0
12
63
1.92
1.23
1.8
1.4
—
—
—
0
0
12
63
1.92
1.23
1.8
1.4
—
—
—
0
0
8
38
2.12
1.19
1.1
2.0
4.70
4.12
umol/l
—
8
24
10
50
2.02
1.17
1.1
1.1
—
—
—
0
0
7
30
2.35
1.12
1.1
1.1
—
—
—
0
0
7
30
2.35
1.12
1.1
1.1
—
—
—
0
0
17
104
1.65
1.10
1.5
1.4
236.75
222.66
miu/ml
—
6
53
159
1397
1.19
1.08
4.7
4.0
20.46
21.99
%
0.56
81
656
19
121
1.59
1.06
1.1
1.7
—
—
—
0
0
6
125
0.47
1.05
1.8
1.5
—
—
—
0
0
22
146
1.53
1.04
1.5
1.1
—
—
—
0
0
22
147
1.52
1.02
1.5
1.1
—
—
—
0
0
37
277
1.36
0.96
1.2
1.3
—
48.31
—
0
18
11
62
1.79
0.94
1.9
1.4
—
—
—
0
0
6
27
2.23
0.93
1.2
1.2
—
—
—
0
0
6
27
2.23
0.93
1.2
1.2
—
—
—
0
0
45
570
0.77
0.91
1.5
1.4
—
—
—
0
0
10
56
1.80
0.88
1.1
1.0
—
—
—
0
0
8
44
1.83
0.86
1.1
1.2
—
—
—
0
0
6
31
1.95
0.84
1.2
1.2
—
—
—
0
0
6
31
1.95
0.84
1.2
1.2
—
—
—
0
0
11
66
1.68
0.79
1.7
1.8
—
—
—
0
0
5
25
2.01
0.73
1.0
1.3
—
—
—
0
0
5
26
1.93
0.70
2.6
2.6
—
—
—
0
0
22
162
1.37
0.67
1.2
1.7
—
—
—
0
0
8
53
1.52
0.58
1.3
1.2
—
—
—
0
0
9
132
0.68
0.52
1.8
1.6
—
—
—
0
0
14
100
1.41
0.52
1.6
1.6
2.85
6.75
iu/l
—
6
32
26
323
0.80
0.50
1.6
1.7
—
—
—
0
0
5
83
0.60
0.46
1.8
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
25
207
1.22
0.37
1.1
1.0
—
—
—
0
0
5
78
0.64
0.36
1.8
1.4
—
—
—
0
0
5
78
0.64
0.36
1.8
1.4
—
—
—
0
0
5
78
0.64
0.36
1.8
1.4
—
—
—
0
0
26
221
1.18
0.31
1.5
1.3
—
—
—
0
0
35
308
1.15
0.28
2.0
1.7
—
—
—
0
0
74
685
1.09
0.26
1.5
1.5
—
—
—
0
0
5
42
1.19
0.21
1.0
1.1
1.53
1.67
nmol/l
—
5
36
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
37
339
1.10
0.18
2.1
1.8
—
—
—
0
0
57
602
0.94
0.14
9.4
7.6
—
—
—
0
0
8
92
0.87
0.07
2.0
1.9
166.75
239.52
pmol/l
—
8
84
13
120
1.09
0.05
1.7
1.9
46.15
40.20
nmol/l
0.70
13
113
61
617
0.99
0.01
4.1
4.7
32.21
32.12
%
0.02
38
411
12
114
1.05
0.00
1.4
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
8
81
0.99
0.00
2.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
6.04
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
6.27
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
23.27
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_OTHER_ABNORMALITI_PLASMA_PROTEINS – Other abnormalities of plasma proteins
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).